Evidence map›Paper›PMID 38179429›Full record

ReviewMaterials today. Bio2024

Nanomaterials augmented bioeffects of ultrasound in cancer immunotherapy.

Xinxin Xie, Jinxia Zhang, Yuan Wang, Wanrui Shi, Rui Tang, Qingshuang Tang, Suhui Sun, Ruiqi Wu, Shuyu Xu, Mengxin Wang and 2 more

Abstract readReview
In one paragraph

Review in Materials today. Bio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Xinxin XieDepartment of Ultrasound, Peking University Third Hospital, Beijing, 100191, P.R. China.
Jinxia ZhangDepartment of Ultrasound, Peking University Third Hospital, Beijing, 100191, P.R. China.
Yuan WangDepartment of Ultrasound, Peking University Third Hospital, Beijing, 100191, P.R. China.
Wanrui ShiDepartment of Ultrasound, Peking University Third Hospital, Beijing, 100191, P.R. China.
Rui TangDepartment of Ultrasound, Peking University Third Hospital, Beijing, 100191, P.R. China.
Qingshuang TangDepartment of Ultrasound, Peking University Third Hospital, Beijing, 100191, P.R. China.
Suhui SunDepartment of Ultrasound, Peking University Third Hospital, Beijing, 100191, P.R. China.
Ruiqi WuDepartment of Ultrasound, Peking University Third Hospital, Beijing, 100191, P.R. China.
Shuyu XuDepartment of Ultrasound, Peking University Third Hospital, Beijing, 100191, P.R. China.
Mengxin WangDepartment of Ultrasound, Peking University Third Hospital, Beijing, 100191, P.R. China.
Xiaolong LiangDepartment of Ultrasound, Peking University Third Hospital, Beijing, 100191, P.R. China.
Ligang CuiDepartment of Ultrasound, Peking University Third Hospital, Beijing, 100191, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immunotherapy as a milestone in cancer treatment has made great strides in the past decade, but it is still limited by low immune response rates and immune-related adverse events. Utilizing bioeffects of ultrasound to enhance tumor immunotherapy has attracted more and more attention, including sonothermal, sonomechanical, sonodynamic and sonopiezoelectric immunotherapy. Moreover, the emergence of nanomaterials has further improved the efficacy of ultrasound mediated immunotherapy. However, most of the summaries in this field are about a single aspect of the biological effects of ultrasound, which is not comprehensive and complete currently. This review proposes the recent progress of nanomaterials augmented bioeffects of ultrasound in cancer immunotherapy. The concept of immunotherapy and the application of bioeffects of ultrasound in cancer immunotherapy are initially introduced. Then, according to different bioeffects of ultrasound, the representative paradigms of nanomaterial augmented sono-immunotherapy are described, and their mechanisms are discussed. Finally, the challenges and application prospects of nanomaterial augmented ultrasound mediated cancer immunotherapy are discussed in depth, hoping to pave the way for cancer immunotherapy and promote the clinical translation of ultrasound mediated cancer immunotherapy through the reasonable combination of nanomaterials augmented ultrasonic bioeffects.

Indexed as

Cancer immunotherapyNanomaterialSonodynamicSonomechanicalSonopiezoelectricSonothermalUltrasound

Identifiers

PMID38179429
PMCPMC10765306

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.